Investing in crypto has never been easier. That's because institutional adoption and increasingly crypto-friendly regulators have opened the door for crypto ETFs. But rather than paying an excessive fee for a crypto ETF, why not make your own? The total digital asset market cap is heavily concentrated into just a few tokens, so it's not difficult to simply invest in those particular coins and call it a day. Which coins are they, and how much should you invest? Watch the video and find out!

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/wdD6NmKgMIQ.

Vertiv stock is trading near its all-time high. Investor optimism for data center stocks is clearly through the roof, but VRT stock isn't the only way to play the data center cooling theme. Today, we'll look at five stocks - plus a bonus stock - that give investors exposure to the high-growth segment of data center thermal management.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/O2Vir_mLVkQ.

NVO stock is either an undervalued gem or a value trap. Let's figure out which. Today, we'll break down the business of Danish drugmaker Novo Nordisk to see why their stock is down nearly 60% from its peak. Is competition from Eli Lilly keeping this European giant down? Or is it simply an execution issue? Or are tariffs wreaking havoc on the company's bottom line? Let's look at all those issues as more to determine if Novo Nordisk stock is a buy now.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/_wy8wm9XFm8.

You're probably making huge mistakes with your 401(k) without even realizing it. In this video, we'll show you how to maximize your 401k profits and avoid the hidden trap for any 401k holder: fees. 401k funds are notorious for high fees and limited investment options, but we're here to help. Every day that passes is another day you're losing money to excessive fees, so don't wait. Save your 401k before it's too late.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/CPePiSai_a8.

UnitedHealth Group is in the midst of extreme controversy. Some analysts are considering it a solid value investing opportunity, while others see significant challenges ahead for United Health. We'll investigate the factors driving these differing perspectives, including recent news and events impacting UNH stock and the ongoing fraud investigation. Is $UNH a blue chip stock to buy and hold forever, or one to avoid?

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/mpSKVOrTTnA.

Life is expensive. It may feel impossible to invest when you're spending all your money on bills, just trying to stay afloat. You're not alone. Today we'll talk about how to invest on a budget. It's crucial to sock away money every month, even if it's just a small amount. That's because the effects of compounding are magical. If you put aside even $100 per month, you'll end up with a substantial sum in the future. How substantial? Watch the video and find out!

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/TfaQOkqutSY.

Here at Nanalyze, we can't emphasize enough the importance of financial independence. The real-world case study with plenty of examples featured in this video involves in-depth professional financial analysis and research. This helps us show you how to effectively navigate a financial portfolio for sustained growth and enhance its longevity. It's never too early to start planning for that period of your life! Plan with us!

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/T65HxkjAJo8.

Carlsmed $CARL is a fascinating company that's using AI to make spine surgery better with custom implants, which could dramatically improve patient outcomes. The global spinal implant market is a multi-billion dollar industry, so the total addressable market is huge. However, it's always wise to do thorough research before getting too excited. In this video, we'll dive into Carlsmed's AI IPO and see if it's a worthy addition to our disruptive technology portfolio. We'll also look at a second AI IPO that wants to be the next Coreweave - WhiteFiber $WYFI

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/tHZz2btBKkA.

There's a new space IPO coming to Wall Street. This company provides launch services for customers like NASA and Lockheed-Martin, but how does it compare to it's bigger rival, Rocket Lab? Today, we'll investigate the upcoming Firefly IPO and uncover some interesting findings such as unusual share classes, high interest debt, and some serious customer concentration risk. Is there anything to like about Firefly? Or is this stock best avoided?

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/hrAJcIr2JRk.

Figma stock recently began trading, up 250% on their first day as a public company. Talk about some serious retail interest. Today, we'll look at Figma's business model, what they do, and what you need to know about this hot new "AI stock." Before you rush out to buy FIG stock, you're going to want to watch this, since we'll uncover some facts you may not have known about Figma. And while the business looks interesting, there's of course the issue of the company's high valuation.

Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/4DkRN4vvhUc.